For those trying to stay up-to-date, a headline from The Onion: “Nation’s Third-Graders Now Eating At A Ninth-Grade Level” http://onion.com/1nWSizb pic.twitter.com/uc3jYNZ16L.
And, from American Association for the Study of Liver Diseases (AASLD):
AASLD and the Infectious Diseases Society of America (IDSA), in collaboration with the International Antiviral Society-USA (IAS-USA), released the latest section of www.hcvguidelines.org.
The new section, “When and in Whom to Initiate HCV Therapy,” offers clinicians information on:
- How to prioritize patients who will derive the most benefit, or will have the greatest impact on limiting further HCV transmission.
- When to treat patients with complications such as advanced fibrosis, compensated cirrhosis, liver transplant, or severe extra-hepatic complications.
- Additional conditions that warrant prioritization of treatment.
Related blog posts:
Pingback: Telaprevir-Based HCV Therapy is Expensive Too | gutsandgrowth